News & Insights

Stay up to date on PsychoGenics’ latest research, press releases, and industry developments in preclinical drug discovery. Combine our expertise with yours to spark the translational power of your next CNS breakthrough.

Explore Updates

PUBLICATION

A standardized in vivo platform for preclinical screening of therapeutic interventions in rat thoracic spinal cord injury

September 30, 2026

PAGE

ASD Models – Shank3/F, Cntnap2-KO, Fmr1-KO

August 12, 2026

Filters

Therapeutic Areas

Drug Abuse Liability
Quality

In Vivo AI Platforms

eCube
SmartCube
NeuroCube
PhenoCube

Biomarker
Bioanalysis

Mental Illness

Anxiety
Depression
Schizophrenia

Neurodegenerative Disorders

Alzheimer’s Disease
Amyotrophic Lateral Sclerosis
Huntington’s Disease
Parkinson’s Disease
Spinal Muscular Atrophy

Neurodevelopmental Disorders

Autism Spectrum Disorder
Rett Syndrome

Neuromuscular Disorders

Amyotrophic Lateral Sclerosis
Charcot-Marie-Tooth
Spinal Muscular Atrophy

Pain

Acute Pain
Inflammatory Pain
Neuropathic Pain
Osteoarthritis Pain
Postoperative Pain
PSPP Program
Visceral Pain

Sleep & Seizure Disorders

Epilepsy
Rett Syndrome
Seizure
Tuberous Sclerosis Complex

Rare CNS Disorders

Charcot-Marie-Tooth
Fragile X Syndrome
Gaucher Disease
Rett Syndrome
Tuberous Sclerosis Complex

Spinal Cord Injury

Traumatic Brain Injury

Spinal Cord Injury
TBI

Specific Disorders

Alzheimer’s Disease
Amyotrophic Lateral Sclerosis
Huntington’s Disease
Parkinson’s Disease
Spinal Muscular Atrophy
ADHD Studies
Angelman Syndrome
Autism Spectrum Disorder
Fragile X Syndrome
Rett Syndrome
Amyotrophic Lateral Sclerosis
Charcot-Marie-Tooth
Duchenne Muscular Dystrophy
Spinal Muscular Atrophy
Angelman Syndrome
Charcot-Marie-Tooth
Dravet Syndrome
Fragile X Syndrome
Gaucher Disease
Rett Syndrome
Tuberous Sclerosis Complex

Apply Filters